Hemant Surgical Industries Ltd

Hemant Surgical Industries Ltd

₹ 98.0 0.00%
11 Jun - close price
About

Incorporated in 1989, Hemant Surgical Industries Ltd is in the business of Medical Equipment & Supplies[1]

Key Points

Business Overview:[1][2]
HSIL is ISO 9001:2015, ISO 13485:2016 certified and CDSCO compliant company which deals in importing, manufacturing, and marketing medical disposable, surgical equipments and pharmaceutical products including
a) Supply of dialysis equipment, renal care, oxygen concentrators, air mattresses, ultrasound machines and digital thermometers, etc.
b) Design and manufacture of a range of nebulisers, which are
marketed under the company’s AERO brand
c) HSIL also refurbishes second-hand dialysis machines, manufactures
and supplies related accessories, dialysers and haemodialysis solutions

  • Market Cap 102 Cr.
  • Current Price 98.0
  • High / Low 225 / 88.2
  • Stock P/E 12.7
  • Book Value 60.5
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value 10.0

Pros

Cons

  • Earnings include an other income of Rs.5.12 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
58
52
Operating Profit 5
OPM % 9%
3
Interest 1
Depreciation 1
Profit before tax 6
Tax % 19%
5
EPS in Rs 4.66
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
107
98
Operating Profit 9
OPM % 8%
5
Interest 2
Depreciation 1
Profit before tax 10
Tax % 23%
8
EPS in Rs 7.70
Dividend Payout % 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -25%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
Equity Capital 10
Reserves 53
31
54
Total Liabilities 148
40
CWIP 12
Investments 1
95
Total Assets 148

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
9
-30
18
Net Cash Flow -4

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2025
Debtor Days 70
Inventory Days 208
Days Payable 188
Cash Conversion Cycle 90
Working Capital Days 88
ROCE %

Shareholding Pattern

Numbers in percentages

Sep 2023Mar 2024Sep 2024Mar 2025
73.56% 73.56% 73.56% 73.56%
0.03% 0.00% 0.00% 0.39%
4.26% 1.97% 1.13% 1.11%
22.14% 24.47% 25.31% 24.93%
No. of Shareholders 7221,2291,2481,229

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents